238 related articles for article (PubMed ID: 12351451)
1. Podocyte number in normotensive type 1 diabetic patients with albuminuria.
White KE; Bilous RW; Marshall SM; El Nahas M; Remuzzi G; Piras G; De Cosmo S; Viberti G
Diabetes; 2002 Oct; 51(10):3083-9. PubMed ID: 12351451
[TBL] [Abstract][Full Text] [Related]
2. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy.
Toyoda M; Najafian B; Kim Y; Caramori ML; Mauer M
Diabetes; 2007 Aug; 56(8):2155-60. PubMed ID: 17536064
[TBL] [Abstract][Full Text] [Related]
3. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
[TBL] [Abstract][Full Text] [Related]
4. Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes.
Moriyama T; Oka K; Ueda H; Imai E
Clin Exp Nephrol; 2004 Sep; 8(3):230-6. PubMed ID: 15480900
[TBL] [Abstract][Full Text] [Related]
5. Podocyte structural parameters do not predict progression to diabetic nephropathy in normoalbuminuric type 1 diabetic patients.
Harindhanavudhi T; Parks A; Mauer M; Caramori ML
Am J Nephrol; 2015; 41(4-5):277-83. PubMed ID: 26021523
[TBL] [Abstract][Full Text] [Related]
6. Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression.
Fioretto P; Steffes MW; Sutherland DE; Mauer M
Kidney Int; 1995 Dec; 48(6):1929-35. PubMed ID: 8587254
[TBL] [Abstract][Full Text] [Related]
7. Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects.
Ahmad J; Shafique S; Abidi SM; Parwez I
Diabetes Res Clin Pract; 2003 May; 60(2):131-8. PubMed ID: 12706322
[TBL] [Abstract][Full Text] [Related]
8. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
Ahmad J; Siddiqui MA; Ahmad H
Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
[TBL] [Abstract][Full Text] [Related]
9. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.
Weil EJ; Lemley KV; Mason CC; Yee B; Jones LI; Blouch K; Lovato T; Richardson M; Myers BD; Nelson RG
Kidney Int; 2012 Nov; 82(9):1010-7. PubMed ID: 22718189
[TBL] [Abstract][Full Text] [Related]
10. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes.
Drummond K; Mauer M;
Diabetes; 2002 May; 51(5):1580-7. PubMed ID: 11978659
[TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus.
Rudberg S; Osterby R; Bangstad HJ; Dahlquist G; Persson B
Diabetologia; 1999 May; 42(5):589-95. PubMed ID: 10333052
[TBL] [Abstract][Full Text] [Related]
12. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P
Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971
[TBL] [Abstract][Full Text] [Related]
13. Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria.
Bangstad HJ; Osterby R; Hartmann A; Berg TJ; Hanssen KF
Diabetes Care; 1999 Feb; 22(2):314-9. PubMed ID: 10333951
[TBL] [Abstract][Full Text] [Related]
14. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
[TBL] [Abstract][Full Text] [Related]
16. Follow-up study of glomerular dimensions and cortical interstitium in microalbuminuric type 1 diabetic patients with or without antihypertensive treatment.
Osterby R; Bangstad HJ; Rudberg S
Nephrol Dial Transplant; 2000 Oct; 15(10):1609-16. PubMed ID: 11007830
[TBL] [Abstract][Full Text] [Related]
17. Serial renal biopsies in normo- and microalbuminuric patients with type 2 diabetes demonstrate that loss of renal function is associated with a reduction in glomerular filtration surface secondary to mesangial expansion.
Moriya T; Yamagishi T; Matsubara M; Ouchi M
J Diabetes Complications; 2019 May; 33(5):368-373. PubMed ID: 30846231
[TBL] [Abstract][Full Text] [Related]
18. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.
Wolf G; Chen S; Ziyadeh FN
Diabetes; 2005 Jun; 54(6):1626-34. PubMed ID: 15919782
[TBL] [Abstract][Full Text] [Related]
19. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.
Thomson SE; McLennan SV; Kirwan PD; Heffernan SJ; Hennessy A; Yue DK; Twigg SM
J Diabetes Complications; 2008; 22(4):284-94. PubMed ID: 18413184
[TBL] [Abstract][Full Text] [Related]
20. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
